Spots Global Cancer Trial Database for Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Official Title: Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Subjects With Unresectable or Metastatic Melanoma
Study ID: NCT02186249
Conditions
Study Description
Brief Summary: The purpose of this study is to provide treatment with nivolumab in combination with ipilimumab to subjects who are anti-(CTLA)-4 and anti-PD-1 treatment-naive and have unresectable or metastatic melanoma.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
Mayo Clinic Arizona, Phoenix, Arizona, United States
6501 Truxtun Avenue, Bakersfield, California, United States
UC San Diego Moores Cancer Center, La Jolla, California, United States
100 UCLA Medical Plaza, Los Angeles, California, United States
514 North Prospect Ave, Redondo Beach, California, United States
California Pacific Medical Center Research Institute, San Francisco, California, United States
University of California San Francisco, San Francisco, California, United States
Angeles Clinic and Research Institute, Santa Monica, California, United States
1325 East Church Street, Santa Monica, California, United States
University of Colorado Hospital, Aurora, Colorado, United States
Rocky Mountain Cancer Centers, Littleton, Colorado, United States
Smilow Cancer Hospital at Yale University Cancer Center, New Haven, Connecticut, United States
Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
Memorial Regional Hospital, Hollywood, Florida, United States
4500 San Pablo Road South, Jacksonville, Florida, United States
Cancer Specialists of North Florida, Jacksonville, Florida, United States
UF Health Cancer Center at Orlando Health, Longwood, Florida, United States
Mount Sinai Medical Center, Miami Beach, Florida, United States
Florida Hospital Cancer Institute, Orlando, Florida, United States
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
Winship Cancer Institute, Atlanta, Georgia, United States
600 Celebrate Life Parkway, Newnan, Georgia, United States
Evanston Premier Healthcare Research LLC, Evanston, Illinois, United States
Oncology Specialists, SC, Niles, Illinois, United States
Local Institution, Louisville, Kentucky, United States
Medstar Health Research Institute, Baltimore, Maryland, United States
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Center For Cancer and Blood Disorders, Bethesda, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
Atlantic Health System, Morristown, New Jersey, United States
NYU Langone Medical Center, New York, New York, United States
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Carolinas Healthcare System, Charlotte, North Carolina, United States
Tulsa Cancer Institute PLLC, Tulsa, Oklahoma, United States
Northwest Cancer Specialists PC, Portland, Oregon, United States
Lehigh Valley Health Network, Allentown, Pennsylvania, United States
St Luke's Hospital, Bethlehem, Pennsylvania, United States
Greenville Health System, Easley, South Carolina, United States
Tennessee Oncology PLLC, Nashville, Tennessee, United States
Texas Oncology, Austin, Texas, United States
MD Anderson Cancer Center, Houston, Texas, United States
Texas Oncology, Midland, Texas, United States
Texas Oncology, Paris, Texas, United States
Virginia Cancer Institute, Richmond, Virginia, United States
Oncology and Hematology Associates of Southwest Virginia, Inc, Roanoke, Virginia, United States
Shenandoah Oncology Association, Winchester, Virginia, United States
Seattle Cancer Care Alliance, Seattle, Washington, United States
University of Wisconsin, Madison, Wisconsin, United States
Cross Cancer Institute, Edmonton, Alberta, Canada
British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Grand River Hospital, Kitchener, Ontario, Canada
London Health Sciences Centre, London, Ontario, Canada
Lakeridge Health Oshawa, Oshawa, Ontario, Canada
Sunnybrook Health Science Centre, Toronto, Ontario, Canada
Princess Margaret Hospital, Toronto, Ontario, Canada
McGill University Health Center, Montreal, Quebec, Canada
Chuq Centre Hospitalier Universitaire de Quebec, Quebec, , Canada
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
